Patent Law Weblog
Month: May 2007
-
Strafford CLE Teleconferences will be offering a telephone conference entitled: "Patent Licensing Post MedImmune: Proceed with Caution: Best Practices for Adapting to Sweeping Change in Licensing" on June 28, 2007 from 1:00-2:30 PM (EST). In January, the Supreme Court rejected the Federal Circuit's long-standing "reasonable apprehension of suit" test in MedImmune v. Genentech, changing the…
-
Practising Law Institute (PLI) will be offering a webcast on the Supreme Court's decision in KSR Int'l Co. v. Teleflex, Inc. on June 13, 2007 from 1:00-2:00 PM (EST). The webcast, entitled "The Scope and Implications of the Supreme Court's Ruling in KSR v. Teleflex on the Doctrine of Patent Obviousness," is the fourth installment…
-
By Robert Dailey — Norwegian biotech Natural ASA has settled its patent infringement suit against ArkoPharma involving conjugated linoleic acid (CLA), a dietary supplement thought to reduce body fat. Natural markets its CLA product in the U.S. under the trademark Tonalin®. (A month’s supply of Tonalin® gel capsules sells for about $25.) Natural…
-
By Donald Zuhn — Last month, Koronis Pharmaceuticals, Inc. announced that the United States Patent and Trademark Office had issued a Notice of Allowance for its application directed to Koronis’ lead HIV therapeutic candidate, KP-1461. The patent that eventually issues from the allowed application will be the first U.S. patent to be awarded…
-
West LEGALworks® will be rebroadcasting its webcast entitled: "KSR International Co. v. Teleflex, Inc.: Discover How the High Court's Ruling Will Alter the Patent Landscape" on May 31, 2007 from 1:00-2:30 PM (EST). Speakers Thomas C. Goldstein of Akin Gump Strauss Hauer & Feld LLP (counsel of record for Teleflex), Robert Greene Sterne and…
-
Federal Circuit Increases Risk for Biotechnology Patent Prosecutors By Kevin E. Noonan — In a decision that might not be noticed by most biotechnology patent prosecutors, McKesson Information Solutions, Inc. v. Bridge Medical, Inc., the Federal Circuit significantly increased the extent to which the duty of candor extends to activities occurring during prosecution…
-
Managing Intellectual Property (MIP) will be offering a webcast entitled "Stating the Obvious: Patent Protection after KSR" on Wednesday, May 30, 2007 from 12:00-1:00 PM (EST). Speakers James Nurton, Editor of MIP; John Dragseth and Katherine Lutton of Fish & Richardson P.C.; and Kevin H. Rhodes, Assistant Chief Intellectual Property Counsel of 3M will discuss…
-
Celesq® AttorneysEd Center will be offering a webcast entitled "Supreme Court IP Roundup, the Court Asserts Itself: A Discussion of the Supreme Court Decisions in KSR International Co. v. Teleflex, Inc.; Microsoft Corp. v. AT&T Corp.; and MedImmune, Inc. v. Genentech, Inc." on Thursday, May 24, 2007 from 12:00-1:00 PM (EST). Speaker Anthony F. Lo…
-
By Donald Zuhn — On Monday, the Federal Circuit denied a combined petition for panel rehearing and rehearing en banc filed by Plaintiff-Appellee Pfizer, Inc. The Federal Circuit’s denial of Pfizer’s petition for rehearing en banc was not unanimous, with Judges Newman, Lourie, and Rader each writing their own dissent. Pfizer had been…
-
By Kevin E. Noonan — Last week, Simran Trana (at right), director of Purdue Research Foundation’s Office of Technology Commercialization acknowledged the 800 lb. gorilla that everyone talking about patent reform has been ignoring. Speaking on a panel discussing patent reform legislation at BIO 2007 in Boston, Ms. Trana said that the need…
Patent Docs 